Expanded Access Program for Revumenib
Public ClinicalTrials.gov record NCT05918913. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Expanded Access Program for SNDX-5613 in Patients With Relapsed/Refractory Acute Leukemias With Genetic Alterations Associated With HOXA Overexpression
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This expanded access program will provide an investigational treatment option in a controlled clinical setting for participants who are not otherwise eligible to participate in other Syndax-sponsored clinical studies and have no approved treatment options.
Study identification
- NCT ID
- NCT05918913
- Recruitment status
- No Longer Available
- Study type
- Expanded access
- Phase
- Not listed
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Months and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Sep 5, 2025
United States locations
- U.S. sites
- 35
- U.S. states
- 21
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alabama Center for Childhood Cancer And Blood Disorders, Children's of Alabama | Birmingham | Alabama | 35233 | — |
| Phoenix Children's Hospital | Phoenix | Arizona | 85016 | — |
| City of Hope | Duarte | California | 91010 | — |
| City of Hope at Orange County Lennar Foundation Cancer Center | Irvine | California | 92618 | — |
| UCLA, UCLA RRMC, Drug Information Center, Department of Pharmaceutical Services Drug Supply Shipment | Los Angeles | California | 90095 | — |
| Lucile Packard Children's Hospital-Stanford | Palo Alto | California | 94304 | — |
| Rady Children's Hospital | San Diego | California | 92123 | — |
| University of California, San Francisco | San Francisco | California | 94158 | — |
| Center for Cancer and Blood Disorders, Colorado Children's Hospital | Aurora | Colorado | 80045 | — |
| HCTU, Division of Hematology, University of Colorado, Anschutz Medical Center | Aurora | Colorado | 80045 | — |
| Advent Health Orlando | Orlando | Florida | 32804 | — |
| Children's Healthcare of Atlanta | Atlanta | Georgia | 30322 | — |
| Winship Cancer Institute at Emory University | Atlanta | Georgia | 30322 | — |
| Lurie Children's Hospital of Chicago | Chicago | Illinois | 60611 | — |
| University of Chicago Medical Center | Chicago | Illinois | 60637 | — |
| University of Iowa Hospitals and Clinics | Iowa City | Iowa | 52242 | — |
| Children's Hospital | New Orleans | Louisiana | 70118 | — |
| Dana-Farber Cancer Institute, Boston Children's Cancer and Blood Disorders Center | Boston | Massachusetts | 02215 | — |
| Children's Mercy Hospital-Kansas City | Kansas City | Missouri | 64108 | — |
| Siteman Cancer Center - Washington University | St Louis | Missouri | 63110 | — |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| Memorial Sloan Kettering Cancer Center | Long Island City | New York | 10065 | — |
| Montefiore Medical Center | The Bronx | New York | 10467 | — |
| Duke University Medical Center | Durham | North Carolina | 27705 | — |
| Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio | 45229 | — |
| Division of Hematology and Oncology, Division of Pulmonary, Critical Care and Sleep Medicine, Vontz Center for Molecular Studies | Cincinnati | Ohio | 45267 | — |
| OSU Medical Center | Columbus | Ohio | 43210 | — |
| Doernbecher Children's Hospital, Oregon Health & Science University | Portland | Oregon | 97239 | — |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | — |
| St. Jude Children's Research Hospital | Memphis | Tennessee | 38105 | — |
| MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| Memorial Hermann-Texas Medical Center | Houston | Texas | 77030 | — |
| Texas Children's Hospital | Houston | Texas | 77030 | — |
| Division of Hematology and Hematologic Malignancies, University of Utah-Huntsman Cancer Hospital | Salt Lake City | Utah | 84112 | — |
| Seattle Children's Research Institute, Seattle Childrens Hospital | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05918913, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 5, 2025 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05918913 live on ClinicalTrials.gov.